NCT02614248

Brief Summary

The purpose of the study is to examine the safety and effectiveness of the use of coconut oil for the prevention and treatment of diaper dermatitis among NICU babies at Genesis Medical Center, Davenport.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
149

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 25, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
5.3 years until next milestone

Results Posted

Study results publicly available

October 15, 2024

Completed
Last Updated

October 15, 2024

Status Verified

September 1, 2024

Enrollment Period

3.5 years

First QC Date

November 16, 2015

Results QC Date

December 9, 2021

Last Update Submit

September 23, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • The Number of Days Free From Diaper Dermatitis

    The number of days free from diaper dermatitis.

    Once, at hospital discharge, an average of 2 weeks

  • The Number of Patients Experiencing Adverse Events

    The number of patients experiencing adverse events.

    Once, at hospital discharge, an average of 2 weeks

Secondary Outcomes (1)

  • The Percent of Parents Stating Satisfaction With the Diaper Dermatitis Treatment Used

    Once, at study completion for hospital discharge, an average of 2 weeks

Study Arms (2)

Coconut Oil

EXPERIMENTAL

Participants in this group will receive a generous layer of organic, unrefined coconut oil applied to the diaper area (buttocks and creases between thighs and hips) at each diaper change. This will continue until the patient is discharged or reaches the primary safety endpoint (skin that is eroded and/or blistered in the diaper area with bleeding).

Other: Organic, Unrefined Coconut Oil

Standard of Care

ACTIVE COMPARATOR

Participants in this group will receive the standard of care for preventing and treating diaper dermatitis at Genesis. This includes no treatment until a diaper dermatitis appears. If diaper dermatitis appears, participants will receive a generous layer of Medline Remedy Phytoplex Z-Guard Skin Protectant applied to the diaper area (buttocks and creases between thighs and hips) at each diaper change. This will continue until the patient is discharged or reaches the primary safety endpoint (skin that is eroded and/or blistered in the diaper area with bleeding).

Other: Medline Remedy Phytoplex Z-Guard Skin Protectant

Interventions

Eligibility Criteria

Age5 Hours - 2 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Babies admitted to the Genesis NICU
  • Anticipated stay in the NICU is ≥ 48 hours
  • Babies wearing diapers 24 hours a day
  • Parent willing to sign informed consent for the study
  • Parent willing to use the test products in the diaper area during the trial
  • Parent willing to not change the type or brand of diaper and wipes during the study
  • Parent willing to refrain from changing any other products whose use may have an effect of their baby's skin condition during the trial

You may not qualify if:

  • Babies with a gestational age \<30 weeks
  • Babies with major congenital malformations
  • Active dermatological conditions other than diaper dermatitis that may affect trial results
  • Known sensitivity to ingredients in trial products
  • Babies whose parents have a hazelnut or coconut allergy
  • Other severe acute medical conditions that may increase the risk associated with trial participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Genesis Medical Center, East Campus

Davenport, Iowa, 52803, United States

Location

MeSH Terms

Conditions

Dermatitis, Contact

Condition Hierarchy (Ancestors)

DermatitisSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, Eczematous

Results Point of Contact

Title
Michelle Martin, RN
Organization
Genesis Medical Center

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2015

First Posted

November 25, 2015

Study Start

January 1, 2016

Primary Completion

June 30, 2019

Study Completion

June 30, 2019

Last Updated

October 15, 2024

Results First Posted

October 15, 2024

Record last verified: 2024-09

Locations